Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Advik Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 0.57 -0.02  | -3.39% -81.90% - 1.09
BSE Price: Oct 22, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 2019 0.57 -0.02 -3.39% 0.57 0.59 2,318 0.57 - 0.57
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 678 P/B: 0.12 NSE Code:
52-Week Range: R 0.57 - 3.28 Dividend Yield: 0.00% BSE Code: 531686
TTM EPS: R -0.63 Book Value: R 4.83 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Advik Laboratories -74.09 -35.96 -50.43 -81.90 -53.71 -43.60 -17.80
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 43.98 -30.58 -34.46
Net Profit 88.28 -10.47 -211.61
EPS 88.28 -0.28 -196.74
Book Value -7.32 -19.28 -14.07
Average
Operating Margin -11.39 -96.17 -54.50
Net Margin -20.84 -121.94 -73.96
Return on Networth -7.74 -20.94 -12.72
Return on Investment -5.91 -14.68 -7.07
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - - -86.67
Operating Profit 21.24 16.94 29.30
Net Profit 17.66 13.52 -32.85
EPS 17.68 13.52 -32.87
TTM
Revenue 0.49 -69.70 -79.78
Operating Profit 4.41 -20.00 -43.59
Net Profit 3.45 -25.57 -38.91
EPS 3.45 -25.60 -38.93
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Advik Laboratories 1.09 0.83 -1.20 -141.36 -7.74 0.12 -
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Oct 10, 2016 Bombay Stock Exchange Ltd  Sell Market 1,173,302 4.87 57.14
May 15, 2015 Dhiru Builders And Promoters Pvt Ltd  Buy Preferential Share 920,150 7.13 65.61
May 15, 2015 Peeyush K Aggarwal / Omakam Pharmaceuticals Pvt Ltd  Buy Preferential Share 2,242,350 7.13 159.88
Nov 21, 2013 Omkam Pharmaceuticals Ltd.  Buy Preferential Share 1,457,650 3.09 45.04
Nov 21, 2013 Peeyush K Aggarwal  Buy Preferential Share 800,000 3.09 24.72
News & Announcements
Contact Information

Company: Advik Laboratories Ltd.

Address: 138, Roz Ka Meo, Industrial Area, Sohna, Mewat Dist, Haryana - 122103 | Phone: 0124-2362471,+91-9813179885

Email: [email protected]

Website: www.advikindia.com

Registrar & Transfer Agent: MAS Services Ltd

Address: T-34, 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi - 110020, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II | Phone: 011-26387281/82/83 | Fax: 011-26387384

Website: www.masserv.com

Essential checks
Altman Z-Score
-0.77
Piotroski F-Score
5
Modified C-Score
1
5-Years Price to Earnings
Not applicable
5-Years Price to Book
0.12
Earnings Yield
EBIT / Enterprise value
-16.28%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59